We are live on
!
Find out more
KBC Group Portfolio holdings
AUM
$39.9B
1-Year Est. Return
29.7%
This Fund
S&P 500
This Quarter
Est. Return
+6.62%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$11.1B
AUM Growth
+$989M
(+9.8%)
Cap. Flow
+$432M
Cap. Flow
% of AUM
3.9%
Top 10 Holdings %
Top 10 Hldgs %
14.96%
Holding
1,372
New
66
Increased
556
Reduced
543
Closed
69
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$45.7M |
| 2 |
Morgan Stanley
MS
|
+$44.1M |
| 3 |
Eli Lilly
LLY
|
+$32.8M |
| 4 |
Meta Platforms (Facebook)
META
|
+$30.1M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$29.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$51.6M |
| 2 |
Oracle
ORCL
|
+$40M |
| 3 |
Equity Residential
EQR
|
+$34.6M |
| 4 |
Citigroup
C
|
+$31.3M |
| 5 |
ExxonMobil
XOM
|
+$26.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.49% |
| 2 | Technology | 14.87% |
| 3 | Financials | 14.25% |
| 4 | Consumer Discretionary | 10.2% |
| 5 | Industrials | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QVCGA
826
DELISTED
QVC Group Inc Series A
QVCGA
| $1.14M | 0.01% |
1,168
+383
| +49% | +$360K |
|
827
MKS Inc
MKSI
$20.1B
| $1.13M | 0.01% |
16,491
| – | – |
|
828
CarMax
KMX
$8.13B
| $1.13M | 0.01% |
19,097
| – | – |
|
829
Pebblebrook Hotel Trust
PEB
$2.15B
| $1.12M | 0.01% |
38,470
-14,611
| -28% | -$423K |
|
830
Rogers Corp
ROG
$2.21B
| $1.12M | 0.01% |
13,076
| – | – |
|
831
National Health Investors
NHI
$3.72B
| $1.12M | 0.01% |
15,426
-9,057
| -37% | -$664K |
|
|
QTS
832
DELISTED
QTS REALTY TRUST, INC.
QTS
| $1.11M | 0.01% |
22,834
-13,636
| -37% | -$684K |
|
833
Lear
LEA
$6.54B
| $1.11M | 0.01% |
7,856
-1,847
| -19% | -$262K |
|
834
Harley-Davidson
HOG
$2.58B
| $1.11M | 0.01% |
18,358
-86,851
| -83% | -$5.1M |
|
835
Bruker
BRKR
$9.57B
| $1.11M | 0.01% |
47,513
| – | – |
|
836
Hormel Foods
HRL
$13.8B
| $1.11M | 0.01% |
31,983
-12,000
| -27% | -$428K |
|
|
XHR
837
Xenia Hotels & Resorts
XHR
$1.9B
| $1.11M | 0.01% |
64,793
-23,528
| -27% | -$422K |
|
|
MODV
838
DELISTED
ModivCare
MODV
| $1.1M | 0.01% |
24,876
+5,767
| +30% | +$237K |
|
839
Patrick Industries
PATK
$2.74B
| $1.1M | 0.01% |
35,053
+13,727
| +64% | +$475K |
|
|
PGNX
840
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $1.1M | 0.01% |
+116,904
| New | +$1.17M |
|
841
Chemours
CC
$2.5B
| $1.1M | 0.01% |
28,573
-8,092
| -22% | -$244K |
|
842
Empire State Realty Trust
ESRT
$872M
| $1.1M | 0.01% |
53,188
-31,040
| -37% | -$641K |
|
|
WOOF
843
DELISTED
VCA Inc.
WOOF
| $1.09M | 0.01% |
11,964
-65,741
| -85% | -$5.9M |
|
844
Verisk Analytics
VRSK
$25.4B
| $1.09M | 0.01% |
13,463
-251
| -2% | -$20.6K |
|
|
GAP
845
The Gap Inc
GAP
$7.23B
| $1.09M | 0.01% |
44,938
-47,269
| -51% | -$1.13M |
|
|
BLUE
846
DELISTED
bluebird bio
BLUE
| $1.09M | 0.01% |
924
| – | – |
|
847
InterDigital
IDCC
$7.87B
| $1.09M | 0.01% |
12,594
-20,374
| -62% | -$1.83M |
|
|
NFBK
848
DELISTED
Northfield Bancorp
NFBK
| $1.06M | 0.01% |
58,811
+13,222
| +29% | +$244K |
|
|
AHT
849
Ashford Hospitality Trust
AHT
$20.9M
| $1.06M | 0.01% |
168
-15
| -8% | -$105K |
|
|
POLY
850
DELISTED
Plantronics, Inc.
POLY
| $1.06M | 0.01% |
19,535
-370
| -2% | -$20.1K |
|
Similar funds
HF
KBC Group's Q1 2017 Portfolio in Review
As of Q1 2017, KBC Group held 1,372 positions worth $11.1B, up 9.8% from $10.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
KBC Group deployed $432M of net new capital in Q1 2017, opening 66 new positions and adding to 556 existing holdings. Its largest new stake was LogMein, Inc.: 156,863 shares worth $15.3M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $51.6M trimmed.
- KBC Group's largest Q1 2017 buy was LogMein, Inc.: 156,863 shares worth $15.3M.
- KBC Group added most to Microsoft in Q1 2017, an estimated $45.7M increase.
- KBC Group's biggest Q1 2017 reduction was Pfizer, cutting an estimated $51.6M.
- KBC Group fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $16.2M.
- KBC Group's ten largest holdings make up 15% of its $11.1B portfolio in Q1 2017.
- KBC Group opened 66 new positions and closed 69 in Q1 2017.
- KBC Group's portfolio value rose 9.8% quarter-over-quarter to $11.1B.
Based on KBC Group's 13F filing for Q1 2017, filed 10 May 2017.